Almac’s North Carolina Facility Doubles Capacity
Almac Clinical Services' site in Durham, N.C., recently doubled its capacity and is a licensed pharmacy. In addition, it successfully passed an FDA inspection earlier this year. The Durham facility was part of the Duke Clinical Research Institute from 1990 to 2000 and provided clinical pharmacy, packaging, distribution and supply chain services, which it continues to do as Almac. The division has seen continued growth from clients operating in the not- for-profit sector on academically based clinical trials.
The unit's staff is experienced with the academically-based trials and has understanding of the full clinical trial process, including disease state knowledge, how patients move through the hospital and pharmacy best practice when working directly with investigators. Project leaders are also involved with writing the CTM section of the clinical protocol through to reconciling drug returned from the clinical sites at close out.
Donna Christopher, VP of Operations at Almac Clinical Services, Durham Facility commented, "As our business continues to evolve under the Almac brand we have stayed close to our roots in academically based clinical trials - an area where our expertise lies. Alongside our core contract services, we also advise many of our clients on how to conduct their trials. From the outset we provide information on clinical input, study materials required, efficient drug kits design as well as full supply chain management in addition to providing training and monitoring to sites. We work together with our Academic clients to ensure their clinical trials are run to maximum efficiency enabling them to focus solely on their trial results. In recent months we have doubled our capacity to enable us to meet the increased demands for our services.”
If you would like more information on the services we provide or are an Academic Institution looking for a partner to manage your clinical trial please visit: http://www.almacgroup.com/clinicalservices/academic-clinical-trials.aspx
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.